Description
Tirzepatide is a dual GIP and GLP-1 receptor agonist utilized in laboratory research involving incretin receptor interactions, peptide signaling pathways, and endocrine-related pathway analysis. It is commonly studied in controlled in vitro environments for its interaction with GIP and GLP-1 receptors and its role in receptor-binding and signaling investigations.
Manufactured under strict quality control standards, this peptide provides high purity and consistency for laboratory and analytical research applications.
Key Research Areas:
β’ GIP and GLP-1 receptor interaction studies
β’ Incretin signaling pathway analysis
β’ Peptide receptor-binding and endocrine pathway investigations
β’ Metabolic process and signaling pathway research
β’ In vitro and analytical laboratory investigations
Product Features:
β’ High-purity research grade peptide
β’ Secure, sealed vial packaging
β’ Reliable consistency for laboratory protocols
β οΈ For laboratory and research use only. Not for human or veterinary consumption, diagnostic, therapeutic, or medical use.



